Interpreting Key Trials
Interpreting the Charisma Study
What is the role of dual antiplatelet therapy with clopidogrel and aspirin?
Mihir R. Bakhru, MD and Deepak L. Bhatt, MD
Cleveland Clinic Journal of Medicine April 2008, 75 (4) 289-295;
Mihir R. Bakhru
Department of Internal Medicine, Cleveland Clinic
Deepak L. Bhatt
Associate Director, Cardiovascular Coordinating Center, Section of Cardiac, Peripheral, and Carotid Intervention, Department of Cardiovascular Medicine, Cleveland Clinic
Associate Professor of Medicine, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University School of Medicine
Principal Investigator, Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) study

Article Information
vol. 75 no. 4 289-295
PubMed
Published By
Print ISSN
Online ISSN
History
- Published online April 1, 2008.
Copyright & Usage
Copyright © 2008 The Cleveland Clinic Foundation. All Rights Reserved.
Cited By...
In this issue
Cleveland Clinic Journal of Medicine
Vol. 75, Issue 4
1 Apr 2008
Interpreting the Charisma Study
Mihir R. Bakhru, Deepak L. Bhatt
Cleveland Clinic Journal of Medicine Apr 2008, 75 (4) 289-295;
Jump to section
Related Articles
- No related articles found.





